瑞戈非尼联合纳武利尤单抗治疗晚期胃癌或结直肠癌的Ⅰb期临床研究
评价者：郜辉1, 王晰程2, 文献合成者：赖晓嵘3

A Phase Ⅰb Clinical Study of Regorafenib Plus Nivolumab in Patients With Advanced Gastric Cancer or Colorectal Cancer
Reviewers：GAO Hui1, WANG Xi-cheng2, Literature Co-worker： LAI Xiao-rong3